Skip to main content

Acute Coronary Syndrome and Coronary Revascularization Procedures

This content explains Acute Coronary Syndrome (ACS), its management including pharmacological interventions and thrombolytic therapy, and coronary revascularization procedures like Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Graft (CABG) surgery.

Save this reading to your study set

Sign up free

Acute Coronary Syndrome (ACS) represents a spectrum of clinical conditions—including unstable angina (UA), NSTEMI, and STEMI—that all involve myocardial ischemia. Because the underlying pathophysiology involves the abrupt stoppage of blood flow, often due to an occlusive thrombus, management is a race against time. In the clinical setting, the guiding principle is "time is muscle"; the faster blood flow is restored, the more myocardial tissue can be salvaged.

This diagram illustrates the spectrum of acute coronary syndrome (ACS), showing the progression from unstable angina with partial plaque to NSTEMI with significant plaque and possible clot, and finally to STEMI with a complete blockage of blood flow due to a thrombus.
This diagram illustrates the spectrum of acute coronary syndrome (ACS), showing the progression from unstable angina with partial plaque to NSTEMI with significant plaque and possible clot, and finally to STEMI with a complete blockage of blood flow due to a thrombus.

Acute Coronary Syndrome (ACS) Implementations

When a patient presents with symptoms of ACS—such as substernal chest pain, shortness of breath, diaphoresis, or a "feeling of doom"—immediate stabilization is required. Initial nursing and medical implementations focus on decreasing myocardial oxygen demand and maintaining perfusion.

Key immediate actions include:

  • Obtaining a 12-lead EKG: This is critical to determine the location and size of the infarction and to differentiate between STEMI and NSTEMI.
  • Oxygen Administration: Maintain oxygen saturation >94%> 94\%.
  • Establishing IV Access: Necessary for the rapid administration of emergency medications.

Pharmacological Interventions

Medications are categorized by their mechanism of action to prevent further clotting and reduce the workload on the heart:

  1. Anti-platelets: Drugs such as ASA (Aspirin) and Plavix are used to prevent further platelet aggregation.
  2. Nitroglycerin (NTG): Administered sublingually or via IV to promote vasodilation. If the patient responds to sublingual doses, long-acting versions (such as an IV continuous infusion or paste) are often required.
  3. Beta Blockers: These are typically administered within 24 hours to reduce heart rate and oxygen demand.
  4. Anti-coagulants: Medications like Heparin or LMW Heparin (Lovenox) are used to prevent clot propagation, especially if the patient is not immediately heading to the catheterization lab.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.